Apoptotic and effector pathways in autoimmunity

Current Opinion in Immunology

Volumn 11, Issue 6, 1999, Pages 684-688

  Chervonsky, Alexander V ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

APOPTOSIS; AUTOIMMUNE DISEASE; CELL DESTRUCTION; EFFECTOR CELL; IMMUNE RESPONSE; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; VIRUS INFECTION;

EID: 0032734010     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)00037-0     Document Type: Review

References (59)

1. Lenardo M., Ka-Ming Chan F., Hornung F., McFarland H., Siegel R., Wang J., Zheng L. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol. 17:1999;221-253.
2. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:1998;86-89.
3. Shlomchik W.D., Couzens M.S., Tang C.B., McNiff J., Robert M.E., Liu J., Shlomchik M.J., Emerson S.G. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 285:1999;412-415. This study suggested that crosspriming with antigens obtained from apoptotic cells in vivo is an unlikely event.
4. Vaux D.L., Haecker G., Strasser A. An evolutionary perspective on apoptosis. Cell. 76:1994;777-779.
5. Jabs T. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol. 57:1999;231-245.
6. Meinl E., Fickenscher H., Thome M., Tschopp J., Fleckenstein B. Anti-apoptotic strategies of lymphotropic viruses. Immunol Today. 19:1998;474-479.
7. Gravanis M.B., Sternby N.H. Incidence of myocarditis. A 10-year autopsy study from Malmo, Sweden. Arch Pathol Lab Med. 115:1991;390-392.
8. Gebhard J.R., Perry C.M., Harkins S., Lane T., Mena I., Asensio V.C., Campbell I.L., Whitton J.L. Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am J Pathol. 153:1998;417-428.
9. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1995;1189-1192.
10. Bellgrau D., Gold D., Selawry H., Moore J., Franzusoff A., Duke R.C. A role for CD95 ligand in preventing graft rejection. Nature. 377:1995;630-632.
11. Wilson S.E., Pedroza L., Beuerman R., Hill J.M. Herpes simplex virus type-1 infection of corneal epithelial cells induces apoptosis of the underlying keratocytes. Exp Eye Res. 64:1997;775-779.
12. French L.E., Hahne M., Viard I., Radlgruber G., Zanone R., Becker K., Muller C., Tschopp J. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J Cell Biol. 133:1996;335-343.
13. Jones N.L., Day A.S., Jennings H.A., Sherman P.M. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun. 67:1999;4237-4242.
14. Tschopp J., Irmler M., Thome M. Inhibition of Fas death signals by FLIPs. Curr Opin Immunol. 10:1998;552-558.
15. Ashkenazi A., Dixit V.M. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 11:1999;255-260.
16. Schneider P., Holler N., Bodmer J.L., Hahne M., Frei K., Fontana A., Tschopp J. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med. 187:1998;1205-1213.
17. Hitoshi Y., Lorens J., Kitada S.I., Fisher J., LaBarge M., Ring H.Z., Francke U., Reed J.C., Kinoshita S., Nolan G.P. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity. 8:1998;461-471.
18. Pitti R.M., Marsters S.A., Lawrence D.A., Roy M., Kischkel F.C., Dowd P., Huang A., Donahue C.J., Sherwood S.W., Baldwin D.T.et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature. 396:1998;699-703.
19. Stassi G., Todaro M., Bucchieri F., Stoppacciaro A., Farina F., Zummo G., Testi R., De Maria R. Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis. J Immunol. 162:1999;263-267.
20. Stassi G., Maria R.D., Trucco G., Rudert W., Testi R., Galluzzo A., Giordano C., Trucco M. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med. 186:1997;1193-1200.
21. Chervonsky A.V., Wang Y., Wong F.S., Visintin I., Flavell R.A., Janeway C.A. Jr., Matis L.A. The role of Fas in autoimmune diabetes. Cell. 89:1997;17-24.
22. Hildeman D.A., Mitchell T., Teague T.K., Henson P., Day B.J., Kappler J., Marrack P.C. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity. 10:1999;735-744. The study found that PCD in T cells may be provoked by a mechanism that was not previously known for this cell type. It also suggests how ROS can regulate other apoptotic mechanisms.
23. Rabinovitch A., Suarez-Pinzon W.L. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol. 55:1998;1139-1149.
24. + T cells. The finding enables correlation of the presentation of specific peptide with the effector mechanisms that it stimulates.
25. Amrani A., Verdaguer J., Anderson B., Utsugi T., Bou S., Santamaria P. Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice. J Clin Invest. 103:1999;1201-1209.
26. Bendelac A., Carnaud C., Boitard C., Bach J.F. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med. 166:1987;823-832.
27. Kagi D., Odermatt B., Seiler P., Zinkernagel R.M., Mak T.W., Hengartner H. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med. 186:1997;989-997.
28. Katz J.D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 268:1995;1185-1188.
29. Crispe I.N. Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity. 1:1994;347-349.
30. Kondo T., Suda T., Fukuyama H., Adachi M., Nagata S. Essential roles of the Fas ligand in the development of hepatitis. Nat Med. 3:1997;409-413.
31. Allison J., Strasser A. Mechanisms of beta cell death in diabetes: a minor role of CD95. Proc Natl Acad Sci USA. 95:1998;13818-13822. The paper shows that Fas-deficiency provides limited protection from effector cells in diabetic NOD mice, suggesting that multiple mechanisms are involved in β cell destruction.
32. + T cells trigger TNFR1 rather than Fas to induce PCD in β cells.
33. Kim Y.H., Kim S., Kim K.A., Yagita H., Kayagaki N., Kim K.W., Lee M.S. Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes. Eur J Immunol. 29:1999;455-465.
34. Green E.A., Eynon E.E., Flavell R.A. Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity. 9:1998;733-743. The study showed (among other findings) that sensitivity of pancreatic β cells to TNF-induced apoptosis is developmentally regulated, indicating that intrinsic properties of target cells may influence the autoimmune disease progression.
35. Jacob C.O., Aiso S., Michie S.A., McDevitt H.O., Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci USA. 87:1990;968-972.
36. Grewal I.S., Grewal K.D., Wong F.S., Picarella D.E., Janeway C.A. Jr., Flavell R.A. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J Exp Med. 184:1996;1963-1974.
37. Sabelko-Downes K.A., Cross A.H., Russell J.H. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J Exp Med. 189:1999;1195-1205.
38. Dittel B.N., Merchant R.M., Janeway C.A. Jr. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol. 162:1999;6392-6400.
39. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
40. Scaffidi C., Schmitz I., Zha J., Korsmeyer S.J., Krammer P.H., Peter M.E. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem. 274:1999;22532-22538. The paper demonstrated that Fas-triggered apoptotic pathways (mitochondria-dependent and -independent) may be preferentially used in different cell types.
41. Hotta M., Tashiro F., Ikegami H., Niwa H., Ogihara T., Yodoi J., Miyazaki J. Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med. 188:1998;1445-1451.
42. Hultgren B., Huang X., Dybdal N., Stewart T.A. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes. 45:1996;812-817.
43. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;50-53.
44. Medzhitov R., Janeway C.A. Jr. An ancient system of host defense. Curr Opin Immunol. 10:1998;12-15.
45. Andre I., Gonzalez A., Wang B., Katz J., Benoist C., Mathis D. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci USA. 93:1996;2260-2263.
46. Wang B., Gonzalez A., Hoglund P., Katz J.D., Benoist C., Mathis D. Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes. 47:1998;1207-1211.
47. Jun H.S., Yoon C.S., Zbytnuik L., van Rooijen N., Yoon J.W. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med. 189:1999;347-358.
48. Kagi D., Odermatt B., Ohashi P.S., Zinkernagel R.M., Hengartner H. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J Exp Med. 183:1996;2143-2152.
49. Ludewig B., Odermatt B., Landmann S., Hengartner H., Zinkernagel R.M. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med. 188:1998;1493-1501.
50. Serreze D.V., Fleming S.A., Chapman H.D., Richard S.D., Leiter E.H., Tisch R.M. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol. 161:1998;3912-3918.
51. Falcone M., Lee J., Patstone G., Yeung B., Sarvetnick N. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J Immunol. 161:1998;1163-1168.
52. Chan O.T., Hannum L.G., Haberman A.M., Madaio M.P., Shlomchik M.J. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med. 189:1999;1639-1648.
53. Wolf S.D., Dittel B.N., Hardardottir F., Janeway C.A. Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med. 184:1996;2271-2278.
54. Li H., Shi F.D., He B., Bakheit M., Wahren B., Berglof A., Sandstedt K., Link H. Experimental autoimmune myasthenia gravis induction in B cell-deficient mice. Int Immunol. 10:1998;1359-1365.
55. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C.et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088. The first paper to identify mutant variants of an 'innate immunity' receptor. Mutations in innate receptors or downstream signaling molecules are likely candidates for initiation of autoimmune diseases.
56. Fu Y.X., Huang G., Wang Y., Chaplin D.D. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. J Exp Med. 187:1998;1009-1018.
57. Kwon B., Youn B-S., Kwon B.S. Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes. Curr Opin Immunol. 11:1999;340-345.
58. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., Boldin M.P. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol. 17:1999;331-367. In-depth review of signaling through TNFR family members and interactions with other signaling pathways.
59. Yang X., Khosravi-Far R., Chang H.Y., Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell. 89:1997;1067-1076.